Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.06
Delayed Data
As of Dec 02
 +0.09 / +2.27%
Today’s Change
3.78
Today|||52-Week Range
10.95
-62.37%
Year-to-Date
Achillion, J&J to Initiate Phase IIb Study on HCV Combo
Dec 01 / Zacks.com - Paid Partner Content
Achillion Pharmaceuticals (ACHN) is Oversold: Can It Recover?
Nov 21 / Zacks.com - Paid Partner Content